Bank Of New York Mellon Corp Celcuity Inc. Transaction History

Bank Of New York Mellon Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.35 - $10.11 $151,720 - $286,709	-28,359 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$7.93 - $13.33 $6,185 - $10,397	780 Added 2.83%	28,359 $265,000
Q4 2021 Feb 11, 2022	BUY	$11.96 - $19.35 $70,575 - $114,184	5,901 Added 27.22%	27,579 $364,000
Q3 2021 Nov 12, 2021	BUY	$17.35 - $24.87 $93,169 - $133,551	5,370 Added 32.93%	21,678 $390,000
Q2 2021 Aug 11, 2021	BUY	$14.25 - $30.93 $12,810 - $27,806	899 Added 5.83%	16,308 $391,000
Q1 2020 May 06, 2020	BUY	$5.79 - $11.78 $5 - $11	1 Added 0.01%	15,409 $100,000
Q4 2019 Feb 14, 2020	SELL	$9.47 - $16.71 $568 - $1,002	-60 Reduced 0.39%	15,408 $163,000
Q3 2019 Nov 07, 2019	SELL	$15.74 - $23.65 $13,441 - $20,197	-854 Reduced 5.23%	15,468 $262,000
Q2 2019 Aug 12, 2019	BUY	$19.88 - $25.0 $12,106 - $15,225	609 Added 3.88%	16,322 $408,000
Q1 2019 May 14, 2019	BUY	$18.38 - $24.44 $4,227 - $5,621	230 Added 1.49%	15,713 $344,000
Q3 2018 Nov 09, 2018	BUY	$20.96 - $30.77 $78,830 - $115,725	3,761 Added 32.08%	15,483 $0
Q2 2018 Aug 06, 2018	BUY	$16.13 - $26.99 $189,075 - $316,376	11,722 New	11,722 $291,000

107

30.3M

30.8K

152K

Ticker CELC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,941,300
Market Cap $190M
Description
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.